← Back to Search

Muscle Relaxant

Not pretreated for Muscle Pain

Phase 3
Waitlist Available
Led By Leighan Bye, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours post succinylcholine administration
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

This trial is testing whether or not a second medication can reduce muscle soreness caused by the first medication given as part of anesthesia.

Eligible Conditions
  • Muscle Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours post succinylcholine administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours post succinylcholine administration for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Myalgias Perceived at 3 Hours
Myalgias at 24 Hours Post Succinylcholine Administration.
Pain Scores
Secondary study objectives
Number of Participants With Observed Presence of Muscle Fasciculation Following Succinylcholine Administration

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Not pretreatedExperimental Treatment1 Intervention
Succinylcholine administration with no Rocuronium pre-treatment
Group II: Pre-treated 2 minutes before succinylcholine administratjionActive Control1 Intervention
Succinylcholine administratjion 2 minutes following Rocuronium pre-treatment
Group III: Pre-treated 1 minute before succinylcholine administrationActive Control1 Intervention
Succinylcholine administration 1 minute following Rocuronium pre-treatment

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,219,758 Total Patients Enrolled
Leighan Bye, MDPrincipal InvestigatorIndiana University
~58 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top